Bacteriophage Therapy Market
Bacteriophage Therapy Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Bacteriophage Therapy Market Size and Growth
The Bacteriophage Therapy market is experiencing significant growth, driven by rising antibiotic resistance and increasing demand for alternative treatments. The global market size is projected to reach approximately $700 million by 2027, with a CAGR of over 10%. Key drivers include innovative research, regulatory advancements, and expanding clinical applications. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Armata Pharmaceuticals, Inc.
◍ Eliava Biopreparations Ltd.
◍ Pherecydes Pharma
◍ Intralytix, Inc.
◍ Phagelux Inc.
◍ Nextbiotics
◍ InnoPhage, Ltd
◍ Locus Biosciences, Inc.
◍ TechnoPhage
◍ Eligo Bioscience SA
◍ Phagomed Biopharma GmbH.
◍ PhagePro, Inc.
◍ Adaptive Phage Therapeutics, Inc.
◍ EnBiotix, Inc.
◍ Intodeworld, Inc.
◍ BiomX Ltd.
◍ Phi Therapeutics
◍ Fixed-phage Ltd.
The competitive landscape of the Bacteriophage Therapy market features companies like Armata Pharmaceuticals, Eliava Biopreparations, and Intralytix, developing phage-based treatments. These firms focus on innovation, partnerships, and clinical trials, contributing to market growth. Sales revenue figures for select firms include:
- Armata Pharmaceuticals: $4 million (2022)
- Locus Biosciences: $8 million (2021)
Request Sample Report
Market Segmentation
By Application
By Product
Oral
Parenteral ◍ Organ Transplantation ◍ Bacterial Infections
Alcoholic Hepatitis
Other
Request Sample Report
Topical
$ 925.47 Million
Request Sample Report
